Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

FADI SAMIR BRAITEH

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1538268438
CMS profile
296494
Location
LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$704,212.43

848 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 6 of 17; records 251–300 of 848 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

FADI SAMIR BRAITEH

NPI 1538268438 · CMS profile ID 296494

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 6 of 17; records 251–300 of 848 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1538268438?year=2019&recipient=provider&page=6#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
FADI SAMIR BRAITEH, NPI 1538268438, CMS profile ID 296494. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 17; records 251–300 of 848 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1538268438?year=2019&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). FADI SAMIR BRAITEH, NPI 1538268438, CMS profile ID 296494. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 17; records 251–300 of 848 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1538268438?year=2019&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
FADI SAMIR BRAITEH, NPI 1538268438, CMS profile ID 296494, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 6 of 17; records 251–300 of 848 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1538268438?year=2019&recipient=provider&page=6#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

848 matching records · $704,212.43 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 848 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 251–300 of 848.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $15.7608/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657819735 CMS
Lilly USA, LLC $19.4208/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657826591 CMS
Lilly USA, LLC $15.2508/01/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657826593 CMS
Lilly USA, LLC $77.8208/01/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657826595 CMS
Amgen Inc. $4.8107/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662340691 CMS
PFIZER INC. $4.4007/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672364323 CMS
Amgen Inc. $384.2907/30/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662340733 CMS
Amgen Inc. $5.0007/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662340689 CMS
Bayer HealthCare Pharmaceuticals Inc. $7,040.0007/29/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 628483923 CMS
Puma Biotechnology, Inc. $775.0407/29/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706017561 CMS
Exelixis Inc. $40.0007/27/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555283 CMS
Exelixis Inc. $15.2507/27/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555285 CMS
Celgene Corporation $811.9807/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672919835 CMS
Celgene Corporation $299.8607/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672920877 CMS
Celgene Corporation $1,322.0007/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672926378 CMS
Celgene Corporation $7,125.0007/26/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672927125 CMS
Celgene Corporation $134.1207/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672969711 CMS
Celgene Corporation $11.7607/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672974445 CMS
Exelixis Inc. $3,960.0007/26/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555277 CMS
Exelixis Inc. $65.0007/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555279 CMS
Exelixis Inc. $75.0007/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555281 CMS
Exelixis Inc. $35.2407/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555291 CMS
Exelixis Inc. $288.2207/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555295 CMS
Exelixis Inc. $10.3607/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555287 CMS
Exelixis Inc. $53.0007/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555289 CMS
Bayer HealthCare Pharmaceuticals Inc. $5.8007/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 628455741 CMS
Lilly USA, LLC $15.2507/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657809191 CMS
Lilly USA, LLC $2,800.0007/23/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657813115 CMS
Lilly USA, LLC $15.8307/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657826615 CMS
Lilly USA, LLC $1,050.0007/23/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657830047 CMS
Lilly USA, LLC $10.0007/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657830053 CMS
Lilly USA, LLC $18.8607/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657833395 CMS
Amgen Inc. $625.0007/22/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662340761 CMS
E.R. Squibb & Sons, L.L.C. $140.3207/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651272157 CMS
E.R. Squibb & Sons, L.L.C. $40.0007/22/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651272163 CMS
E.R. Squibb & Sons, L.L.C. $84.0907/22/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651272165 CMS
Puma Biotechnology, Inc. $55.0007/22/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706017569 CMS
Puma Biotechnology, Inc. $113.9807/22/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706017571 CMS
Puma Biotechnology, Inc. $73.9807/22/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 706017573 CMS
Bayer HealthCare Pharmaceuticals Inc. $176.4607/20/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 628484369 CMS
Bayer HealthCare Pharmaceuticals Inc. $205.2107/20/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 628484593 CMS
Genentech USA, Inc. $158.4607/20/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681144781 CMS
Genentech USA, Inc. $780.2907/20/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681352869 CMS
Genentech USA, Inc. $48.7707/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681402391 CMS
Genentech USA, Inc. $226.3907/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681406171 CMS
Genentech USA, Inc. $62.2707/20/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681406465 CMS
Genentech USA, Inc. $1,900.0007/20/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 857129471 CMS
Bayer HealthCare Pharmaceuticals Inc. $45.0007/19/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 628483463 CMS
Lilly USA, LLC $2,450.0007/19/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657813083 CMS
Lilly USA, LLC $2,800.0007/19/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657816491 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $704,212.43 848
PY2020 $321,909.52 329
PY2021 $357,274.76 314
PY2022 $196,288.44 224
PY2023 $375,978.27 537
PY2024 $476,540.36 584
PY2025 $299,798.64 429

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $80,415.75 5
PY2023 Principal investigator $302,558.21 120
PY2022 Recipient $5,855.00 4
PY2022 Principal investigator $378,142.39 26
PY2021 Recipient $5,349.58 6
PY2021 Principal investigator $1,563,904.35 150
PY2020 Recipient $8,263.98 7
PY2020 Principal investigator $2,576,476.61 177
PY2019 Recipient $3,600.00 1
PY2019 Principal investigator $1,279,667.37 101

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 BeOne Medicines Ltd. $11,148.00 12/19/2025 Non-covered Recipient Entity
Comprehensive Cancer Centers of Nevada - Central Valley
A Phase 3, Multi-Center, Randomized, Open-Label Clinical Study of Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma No dispute reported 06/30/2026 1190330701
Principal investigator 1 BeOne Medicines Ltd. $11,148.00 11/25/2025 Non-covered Recipient Entity
Comprehensive Cancer Centers of Nevada - Central Valley
A Phase 3, Multi-Center, Randomized, Open-Label Clinical Study of Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma No dispute reported 06/30/2026 1190330679
Principal investigator 1 BeOne Medicines Ltd. $22,296.00 11/25/2025 Non-covered Recipient Entity
Comprehensive Cancer Centers of Nevada - Central Valley
A Phase 3, Multi-Center, Randomized, Open-Label Clinical Study of Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma No dispute reported 06/30/2026 1190330681
Principal investigator 1 Janssen Research & Development, LLC $34,750.00 05/01/2025 Non-covered Recipient Entity
ALLISON CURTIS KINGSLEY MEOZ MICHAE L & SANCHEZ PC
A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer No dispute reported 06/30/2026 1175427363
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,073.75 01/30/2025 Non-covered Recipient Entity
Comprehensive Cancer Centers Of Nevada
Phase1/2a FirstInHuman Study of BMS986218 Monoclonal Antibody Alone and in Combination With Nivolumab in Advanced Solid Tumors No dispute reported 06/30/2026 1235997858